Now trending

5 most popular innovation stories in Houston this week

From Station Houston's third anniversary to Virgin Trains barreling toward Houston, here's what stories readers flocked to this week. Courtesy of Station Houston

Editor's note: The first week of February was full of news — from new train routes potentially on track for Texas to a Houston nonprofit incubator announcing Houston's innovation ecosystem's maturity. Per usual, readers flocked to our events roundup and three innovators to know. Check out what else InnovationMap readers were interested in this month.

10 can't-miss Houston business and innovation events for February

Check out these workshops, networking events, pitch events, and other goings on in Houston this month. Getty Images

After what's felt like ages, 2019 has transitioned into a new month. For some, February means pink and red hearts. For Houstonians, it means the start of Rodeo Houston later this month. But, for entrepreneurs, the month yields a flurry of networking and professional events around town. Read more.

3 Houston tech innovators to know this week

Tech startups are popping up across industries from real estate to oil and gas, and these three founders are among the leaders in technology. Courtesy images

Often, technology and innovation are mistaken for each other. While not mutually exclusive, both tech and innovation work well together in Houston across all industries — from oil and gas to real estate and social media. These three founders engaged technology for their individual startups. Read more.

Transportation company steers talk of high-speed trains between Houston, Austin, and San Antonio

Virgin Trains may be speeding into Texas. Photo courtesy of Virgin Trains

You've likely heard of the proposed high-speed "bullet" train that would connect Houston and Dallas, as well as the proposed transportation-in-a-tube concept that would link Houston, Austin, Dallas, San Antonio, and Laredo. Now, another possible alternative to planes, Amtrak trains, and automobiles has chugged into the picture. Read more.

Mayor, Station CEO: Houston's innovation ecosystem has arrived

The new two-story wall in Station Houston's space represents Station's promise to its startup members as well as showcases the city's stewards for innovation. Natalie Harms/InnovationMap

For Station Houston on its third anniversary, Houston's not just an up-and-coming innovation leader.

"Houston's tech ecosystem is here. It exists now. It will continue to grow and gain momentum. It is not a thing of the future; it is here now," Gaby Rowe, CEO of Station Houston, tells InnovationMap. Read more.

Here's what the Bay Area can learn from Houston

When it comes to maintaining a good ecosystem, diversity is key. Houston learned that the hard way. Photo by Tim Leviston/Getty Images

Hello Bay Area! We Houstonians are concerned about you. We think your economy is becoming overly dependent on Silicon Valley. In 2018, the technology industry accounted for around 62 percent of all office leasing activity in San Francisco. From September 2017 to September 2018, tech companies and realty investors bought $1.43 billion worth of San Jose downtown properties, nearly three times what they spent the year before on property in the city. Read more.

Trending News



MD Anderson has tapped an innovative new company to improve the efficacy of cancer treatments. Photo via

The sad reality is that not every cancer responds to medication, but a new collaboration is taking steps to close the gaps for scores of patients who were previously left without a clear solution.

The University of Texas MD Anderson Cancer Center and Nexo Therapeutics announced last week that they are collaborating, a move that could lead to the discovery of therapies that could work for patients with limited treatment options.

The Colorado- and Massachusetts-based company joins forces with Houston’s cancer-fighting powerhouse after emerging from stealth with a $60 million series A.

“For many cancer patients, there are no therapies that target the fundamental drivers of their disease,” says Nexo’s founder and CEO, Andrew Phillips, in a press release. He goes on to say that the company’s innovations in covalent chemistry and chemical biology, along with cancer biology and medical chemistry allows it to advance novel therapies.

But in order to get the drugs that Nexo creates onto the market, it is taking advantage of MD Anderson’s first-rate translational research and expertise in drug development. Specifically, Nexo will work with MD Anderson’s TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in ONcology) platform. The pairing will allow the two bodies to accelerate the development of small-molecule therapies through drug-enabling studies.

“Together with Nexo’s innovative platform, our integrated approach to translational research and drug development is poised to design and rapidly advance novel therapies against high priority oncology targets,” says Tim Heffernan vice president of Oncology Research for TRACTION at MD Anderson, in a press release. “This collaboration highlights our commitment to advancing innovative new medicines that address critical unmet needs for our patients.”

TRACTION is part of MD Anderson’s Therapeutics Discovery Division. It combines a team of doctors, researchers, and drug development specialists to bring therapies from discovery to clinical trials. TRACTION researchers will work with Nexo to identify cancers that might be susceptible to their treatments, then find strategies to target them, and finally use biomarkers to help optimize patient selection.

Nexo will help to provide funding to support this research and will retain rights to programs under the collaboration, and will take sole responsibility for development, manufacturing, and commercialization. Meanwhile, MD Anderson may receive royalties and future payments based on milestones as they are obtained. But the real reward will be treating patients who were previously low on options.

Trending News